MNK99
Well-Known Member
- Messages
- 5,560
- Deleted by MNK99
-- I used lamictal for a short time, pre fin. when they thought I had Bipolar ii and ADHD, never made it to titration phase of a higher dosage. Tremors for lith weren't tremors, but it was joint instability. Seems it isn't that great but not bad for PTSD. "Given this and the risks and potential side effects of these agents, they are recommended against for the treatment of PTSD in the guideline." What about autism. Or aspergers?
-- Studies of tegretol and lamotrigine for autism and aspergers and ADHD
--not helpful but can be.. but not recommended I guess.
--I guess, it diet and mineral balancing are the best way to go. besides can mess up hair and vision with lamictal more. It hurt both before. It does work decently well, helped a lot of people.
Mineral balancing or food only should be good. It is hard to stick to carnivore but I will keep trying.
PubMed
Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial
In autism, glutamate may be increased or its receptors up-regulated as part of an excitotoxic process that damages neural networks and subsequently contributes to behavioral and cognitive deficits seen in the disorder. This was a double-blind, placebo-controlled, parallel group study of lamotrigine,...
Author: K M Belsito
Published: 2001/4
Keywords: National Institutes of Health; National Center for Biotechnology Information; National Library of Medicine; MEDLINE;
National Center for Biotechnology Information
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
ASD is a complex neurodevelopmental, biologically based condition with an estimated prevalence of 1 in 44 people [1] that impacts all areas of child development — from behavior, problem solving abilities and self-care skills, to complex social communication ability, language, and executive functioni...
Author: Ramkumar Aishworiya, Tatiana Valica, Randi Hagerman, Bibiana Restrepo
Published: 2022/01
Publication: Neurotherapeutics. 2022 Jan; 19(1): 248–262.
National Center for Biotechnology Information
Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials
Available pharmacotherapies for autism spectrum disorders (ASD) are reviewed based on clinical and research experience, highlighting some older drugs with emerging evidence. Several medications show efficacy in ASD, though controlled studies in ASD are largely lacking. Only risperidone and aripipraz...
Author: Jessica Hellings
Published: 2023/06/06
Publication: World J Psychiatry. 2023 Jun 19; 13(6): 262–277.
ResearchGate
Lamotrigine Therapy for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
In autism, glutamate may be increased or its receptors up-regulated as part of an excitotoxic process that damages neural networks and subsequently contributes to behavioral and cognitive deficits seen in the disorder. This was a double-blind, placebo-controlled, parallel group study of lamotrigine,...
Published: 2001/05/01
DOI: 10.1023/A:1010799115457
National Center for Biotechnology Information
Practitioner’s review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions
Autism spectrum disorder (ASD) is a common [73], complex, genetically based, disabling disorder [15] that needs specific knowledge and parenting skills [165] and burdensome, costly treatment. The complex clinical picture is characterized in ICD-11 6A02 [320] by Persistent deficits in the abilit...
Author: Christian Popow, Susanne Ohmann, Paul Plener
Published: 2021
Publication: Neuropsychiatr. 2021; 35(3): 113–134.
National Center for Biotechnology Information
Pharmacological Therapies for Autism Spectrum Disorder: A Review
Medications are often added to behavioral therapy to help patients with autism spectrum disorder function successfully. This review discusses approved and off-label pharmacotherapeutic options for the various symptoms of the disorder.
Author: Sheena LeClerc, Deidra Easley
Published: 2015/06
Publication: P T. 2015 Jun; 40(6): 389–397.
Global web icon
National Center for Biotechnology Information
National Center for Biotechnology Information › pmc › articles
Randomised controlled trials of mood stabilisers for people with …
Feb 24, 2022 · We included eight RCTs (four on valproate, two on levetiracetam, and one each on lamotrigine and topiramate) that included a total of 310 people with ASD, primarily children. Outcomes were based on core and associated ASD symptoms including irritability and …
DOI: 10.1192/bjo.2022.18
Published: 2022/03
Publication: BJPsych Open. 2022 Mar; 8(2): e52
this other abstract:
Abstract
In autism, glutamate may be increased or its receptors up-regulated as part of an excitotoxic process that damages neural networks and subsequently contributes to behavioral and cognitive deficits seen in the disorder. This was a double-blind, placebo-controlled, parallel group study of lamotrigine, an agent that modulates glutamate release. Twenty-eight children (27 boys) ages 3 to 11 years (M = 5.8) with a primary diagnosis of autistic disorder received either placebo or lamotrigine twice daily. In children on lamotrigine, the drug was titrated upward over 8 weeks to reach a mean maintenance dose of 5.0 mg/kg per day. This dose was then maintained for 4 weeks. Following maintenance evaluations, the drug was tapered down over 2 weeks. The trial ended with a 4-week drug-free period. Outcome measures included improvements in severity and behavioral features of autistic disorder (stereotypies, lethargy, irritability, hyperactivity, emotional reciprocity, sharing pleasures) and improvements in language and communication, socialization, and daily living skills noted after 12 weeks (the end of a 4-week maintenance phase). We did not find any significant differences in improvements between lamotrigine or placebo groups on the Autism Behavior Checklist, the Aberrant Behavior Checklist, the Vineland Adaptive Behavior scales, the PL-ADOS, or the CARS. Parent rating scales showed marked improvements, presumably due to expectations of benefits.
-IDK... I don't know what I have but I fit HSD the most and it often comes with C-PTSD, ASD, and ADHD. I am likely correct or mostly correct.
-DIET and minerals... I could have some Aspergers or Autistic features, and some C-PTSD, etc. For sure trauma. I gotta give diet a full go. ANd keep it clean. Lite test cream use, maybe no test e, or use for a time.
-take some lith orotate if need be.. and low dose anavar.
DIet has helped ppl with Aspergers, Schizoaffective, Bipolar, Autism, and ADHD, and trauma... so it should help me. Maybe not as fast as I want it to.
-- Studies of tegretol and lamotrigine for autism and aspergers and ADHD
--not helpful but can be.. but not recommended I guess.
--I guess, it diet and mineral balancing are the best way to go. besides can mess up hair and vision with lamictal more. It hurt both before. It does work decently well, helped a lot of people.
Mineral balancing or food only should be good. It is hard to stick to carnivore but I will keep trying.
PubMed
Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial
In autism, glutamate may be increased or its receptors up-regulated as part of an excitotoxic process that damages neural networks and subsequently contributes to behavioral and cognitive deficits seen in the disorder. This was a double-blind, placebo-controlled, parallel group study of lamotrigine,...
Author: K M Belsito
Published: 2001/4
Keywords: National Institutes of Health; National Center for Biotechnology Information; National Library of Medicine; MEDLINE;
National Center for Biotechnology Information
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
ASD is a complex neurodevelopmental, biologically based condition with an estimated prevalence of 1 in 44 people [1] that impacts all areas of child development — from behavior, problem solving abilities and self-care skills, to complex social communication ability, language, and executive functioni...
Author: Ramkumar Aishworiya, Tatiana Valica, Randi Hagerman, Bibiana Restrepo
Published: 2022/01
Publication: Neurotherapeutics. 2022 Jan; 19(1): 248–262.
National Center for Biotechnology Information
Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials
Available pharmacotherapies for autism spectrum disorders (ASD) are reviewed based on clinical and research experience, highlighting some older drugs with emerging evidence. Several medications show efficacy in ASD, though controlled studies in ASD are largely lacking. Only risperidone and aripipraz...
Author: Jessica Hellings
Published: 2023/06/06
Publication: World J Psychiatry. 2023 Jun 19; 13(6): 262–277.
ResearchGate
Lamotrigine Therapy for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
In autism, glutamate may be increased or its receptors up-regulated as part of an excitotoxic process that damages neural networks and subsequently contributes to behavioral and cognitive deficits seen in the disorder. This was a double-blind, placebo-controlled, parallel group study of lamotrigine,...
Published: 2001/05/01
DOI: 10.1023/A:1010799115457
National Center for Biotechnology Information
Practitioner’s review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions
Autism spectrum disorder (ASD) is a common [73], complex, genetically based, disabling disorder [15] that needs specific knowledge and parenting skills [165] and burdensome, costly treatment. The complex clinical picture is characterized in ICD-11 6A02 [320] by Persistent deficits in the abilit...
Author: Christian Popow, Susanne Ohmann, Paul Plener
Published: 2021
Publication: Neuropsychiatr. 2021; 35(3): 113–134.
National Center for Biotechnology Information
Pharmacological Therapies for Autism Spectrum Disorder: A Review
Medications are often added to behavioral therapy to help patients with autism spectrum disorder function successfully. This review discusses approved and off-label pharmacotherapeutic options for the various symptoms of the disorder.
Author: Sheena LeClerc, Deidra Easley
Published: 2015/06
Publication: P T. 2015 Jun; 40(6): 389–397.
Global web icon
National Center for Biotechnology Information
National Center for Biotechnology Information › pmc › articles
Randomised controlled trials of mood stabilisers for people with …
Feb 24, 2022 · We included eight RCTs (four on valproate, two on levetiracetam, and one each on lamotrigine and topiramate) that included a total of 310 people with ASD, primarily children. Outcomes were based on core and associated ASD symptoms including irritability and …
DOI: 10.1192/bjo.2022.18
Published: 2022/03
Publication: BJPsych Open. 2022 Mar; 8(2): e52
this other abstract:
Abstract
In autism, glutamate may be increased or its receptors up-regulated as part of an excitotoxic process that damages neural networks and subsequently contributes to behavioral and cognitive deficits seen in the disorder. This was a double-blind, placebo-controlled, parallel group study of lamotrigine, an agent that modulates glutamate release. Twenty-eight children (27 boys) ages 3 to 11 years (M = 5.8) with a primary diagnosis of autistic disorder received either placebo or lamotrigine twice daily. In children on lamotrigine, the drug was titrated upward over 8 weeks to reach a mean maintenance dose of 5.0 mg/kg per day. This dose was then maintained for 4 weeks. Following maintenance evaluations, the drug was tapered down over 2 weeks. The trial ended with a 4-week drug-free period. Outcome measures included improvements in severity and behavioral features of autistic disorder (stereotypies, lethargy, irritability, hyperactivity, emotional reciprocity, sharing pleasures) and improvements in language and communication, socialization, and daily living skills noted after 12 weeks (the end of a 4-week maintenance phase). We did not find any significant differences in improvements between lamotrigine or placebo groups on the Autism Behavior Checklist, the Aberrant Behavior Checklist, the Vineland Adaptive Behavior scales, the PL-ADOS, or the CARS. Parent rating scales showed marked improvements, presumably due to expectations of benefits.
-IDK... I don't know what I have but I fit HSD the most and it often comes with C-PTSD, ASD, and ADHD. I am likely correct or mostly correct.
-DIET and minerals... I could have some Aspergers or Autistic features, and some C-PTSD, etc. For sure trauma. I gotta give diet a full go. ANd keep it clean. Lite test cream use, maybe no test e, or use for a time.
-take some lith orotate if need be.. and low dose anavar.
DIet has helped ppl with Aspergers, Schizoaffective, Bipolar, Autism, and ADHD, and trauma... so it should help me. Maybe not as fast as I want it to.